PivNG primers and probes set used in the cobas omni Utility Channel is a reliable supplemental test for detection of Neisseria gonorrhoeae in oropharyngeal, urogenital and rectal specimens collected in cobas PCR Media
暂无分享,去创建一个
M. Njoya | M. Lewinski | R. Arcenas | M. Hopkins | Selena Singh | D. Perinpanathan | X. Couto-Parada | Avneet Hansra | R. Sheriff
[1] T. Meyer,et al. The Laboratory Diagnosis of Neisseria gonorrhoeae: Current Testing and Future Demands , 2020, Pathogens.
[2] S. Sadiq,et al. 2018 UK national guideline for the management of infection with Neisseria gonorrhoeae , 2019, International journal of STD & AIDS.
[3] E. Marlowe,et al. Evaluation of the Performance of the Cobas CT/NG Test for Use on the Cobas 6800/8800 Systems for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Male and Female Urogenital Samples , 2019, Journal of Clinical Microbiology.
[4] E. Marlowe,et al. High-Throughput Testing of Urogenital and Extragenital Specimens for Detection of Chlamydia Trachomatis and Neisseria Gonorrhoeae with Cobas® CT/NG , 2017, European journal of microbiology & immunology.
[5] C. Bromhead,et al. Supplementary Testing Is Not Required in the cobas 4800 CT/NG Test for Neisseria gonorrhoeae Weak-Positive Urogenital Samples , 2014, Journal of Clinical Microbiology.
[6] S. Corden,et al. Is confirmatory testing of Roche cobas 4800 CT/NG test Neisseria gonorrhoeae positive samples required? Comparison of the Roche cobas 4800 CT/NG test with an opa/pap duplex assay for the detection of N gonorrhoeae , 2014, Sexually Transmitted Infections.
[7] D. Goldmeier,et al. Sexually Transmitted Infections (STIs). , 2009, Journal of midwifery & women's health.
[8] D. Whiley,et al. Nucleic acid amplification testing for Neisseria gonorrhoeae: an ongoing challenge. , 2006, The Journal of molecular diagnostics : JMD.